Nicole Bassler

75 Commercial Road
Melbourne, VIC 3004, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

An engineered T-cell engager with selectivity for high mesothelin-expressing cells and activity in the presence of soluble mesothelin.

An engineered T-cell engager with selectivity for high mesothelin-expressing cells and activity in the presence of soluble mesothelin.

Journal: Oncoimmunology
Published: July 17, 2023

P2Y12 receptor blockers are anti-inflammatory drugs inhibiting both circulating monocytes and macrophages including THP-1 cells.

P2Y12 receptor blockers are anti-inflammatory drugs inhibiting both circulating monocytes and macrophages including THP-1 cells.

Journal: Scientific reports
Published: January 18, 2021

A DARPin targeting activated Mac-1 is a novel diagnostic tool and potential anti-inflammatory agent in myocarditis, sepsis and myocardial infarction.

A DARPin targeting activated Mac-1 is a novel diagnostic tool and potential anti-inflammatory agent in myocarditis, sepsis and myocardial infarction.

Journal: Basic research in cardiology
Published: July 31, 2020

Lysophosphatidylcholine is a Major Component of Platelet Microvesicles Promoting Platelet Activation and Reporting Atherosclerotic Plaque Instability.

Lysophosphatidylcholine is a Major Component of Platelet Microvesicles Promoting Platelet Activation and Reporting Atherosclerotic Plaque Instability.

Journal: Thrombosis and haemostasis
Published: August 06, 2019

LIM kinase 2 (LIMK2) may play an essential role in platelet function.

LIM kinase 2 (LIMK2) may play an essential role in platelet function.

Journal: Experimental cell research
Published: July 19, 2019

Pharmacological inhibition of LIM kinase pathway impairs platelets functionality and facilitates thrombolysis.

Pharmacological inhibition of LIM kinase pathway impairs platelets functionality and facilitates thrombolysis.

Journal: Experimental cell research
Published: January 10, 2019

HMGB1 binds to activated platelets via the receptor for advanced glycation end products and is present in platelet rich human coronary artery thrombi.

HMGB1 binds to activated platelets via the receptor for advanced glycation end products and is present in platelet rich human coronary artery thrombi.

Journal: Thrombosis and haemostasis
Published: December 29, 2014

Coinhibitory suppression of T cell activation by CD40 protects against obesity and adipose tissue inflammation in mice.

Coinhibitory suppression of T cell activation by CD40 protects against obesity and adipose tissue inflammation in mice.

Journal: Circulation
Published: March 26, 2014

Circulating microparticles generate and transport monomeric C-reactive protein in patients with myocardial infarction.

Circulating microparticles generate and transport monomeric C-reactive protein in patients with myocardial infarction.

Journal: Cardiovascular research
Published: July 17, 2012

Microparticles: major transport vehicles for distinct microRNAs in circulation.

Microparticles: major transport vehicles for distinct microRNAs in circulation.

Journal: Cardiovascular research
Published: January 20, 2012

Pentameric CRP attenuates inflammatory effects of mmLDL by inhibiting mmLDL--monocyte interactions.

Pentameric CRP attenuates inflammatory effects of mmLDL by inhibiting mmLDL--monocyte interactions.

Journal: Atherosclerosis
Published: November 06, 2011

Binding of CD40L to Mac-1's I-domain involves the EQLKKSKTL motif and mediates leukocyte recruitment and atherosclerosis--but does not affect immunity and thrombosis in mice.

Binding of CD40L to Mac-1's I-domain involves the EQLKKSKTL motif and mediates leukocyte recruitment and atherosclerosis--but does not affect immunity and thrombosis in mice.

Journal: Circulation research
Published: October 15, 2011
Showing 1-12 of 13

Last Updated: 09/26/2026